| |
| |
|
| Insider
Information: |
Trizzino John |
| Relationship: |
President and COO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,972 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,056 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,972 |
|
|
| Total
Value |
$10,056 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President and COO |
2024-03-10 |
27,972 |
2011-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-08-18 |
4 |
S |
$142.85 |
$6,366,182 |
D/D |
(42,788) |
5,087 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-08-18 |
4 |
OE |
$27.00 |
$2,179,986 |
D/D |
42,788 |
47,875 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-26 |
4 |
D |
$113.56 |
$1,943,807 |
D/D |
(17,117) |
23,408 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,438 |
25,117 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
D |
$111.18 |
$233,812 |
D/D |
(2,103) |
50,658 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
D |
$111.18 |
$27,461 |
D/D |
(247) |
52,761 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
OE |
$5.95 |
$176,120 |
D/D |
29,600 |
53,008 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,757,456 |
D/D |
(25,000) |
25,658 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-29 |
4 |
AS |
$106.04 |
$1,965,630 |
D/D |
(18,321) |
7,337 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-30 |
4 |
AS |
$107.60 |
$248,002 |
D/D |
(2,250) |
5,087 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-13 |
4 |
AS |
$231.29 |
$1,764,433 |
D/D |
(7,499) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-13 |
4 |
OE |
$19.08 |
$143,081 |
D/D |
7,499 |
8,217 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-14 |
4 |
OE |
$19.08 |
$143,081 |
D/D |
7,499 |
8,217 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-14 |
4 |
AS |
$233.17 |
$1,774,360 |
D/D |
(7,499) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-20 |
4 |
OE |
$19.08 |
$143,100 |
D/D |
7,500 |
8,218 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-20 |
4 |
AS |
$223.18 |
$1,706,748 |
D/D |
(7,500) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-21 |
4 |
AS |
$223.95 |
$1,705,265 |
D/D |
(7,500) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-21 |
4 |
OE |
$19.08 |
$143,100 |
D/D |
7,500 |
8,218 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-26 |
4 |
D |
$248.16 |
$424,105 |
D/D |
(1,709) |
2,546 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,537 |
4,255 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-27 |
4 |
OE |
$19.08 |
$143,119 |
D/D |
7,501 |
10,047 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-27 |
4 |
AS |
$228.69 |
$1,759,833 |
D/D |
(7,501) |
2,546 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-28 |
4 |
OE |
$19.08 |
$143,119 |
D/D |
7,501 |
10,047 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-28 |
4 |
AS |
$203.26 |
$1,574,637 |
D/D |
(7,501) |
2,546 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
4,146 |
0 |
- |
|
91 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
